MX9201916A - DERIVATIVES OF 4-ARYL-3-HETERO ARYL UREID QUINOLINE AS ANTI-HYPERCHOLESTEROLEMIC AND ANTI-ATHEROSCLEROSIC AGENTS. - Google Patents

DERIVATIVES OF 4-ARYL-3-HETERO ARYL UREID QUINOLINE AS ANTI-HYPERCHOLESTEROLEMIC AND ANTI-ATHEROSCLEROSIC AGENTS.

Info

Publication number
MX9201916A
MX9201916A MX9201916A MX9201916A MX9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A MX 9201916 A MX9201916 A MX 9201916A
Authority
MX
Mexico
Prior art keywords
aryl
atherosclerosic
ureid
hypercholesterolemic
quinoline
Prior art date
Application number
MX9201916A
Other languages
Spanish (es)
Inventor
Ernest S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9201916A publication Critical patent/MX9201916A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
MX9201916A 1991-04-26 1992-04-24 DERIVATIVES OF 4-ARYL-3-HETERO ARYL UREID QUINOLINE AS ANTI-HYPERCHOLESTEROLEMIC AND ANTI-ATHEROSCLEROSIC AGENTS. MX9201916A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26

Publications (1)

Publication Number Publication Date
MX9201916A true MX9201916A (en) 1992-11-01

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201916A MX9201916A (en) 1991-04-26 1992-04-24 DERIVATIVES OF 4-ARYL-3-HETERO ARYL UREID QUINOLINE AS ANTI-HYPERCHOLESTEROLEMIC AND ANTI-ATHEROSCLEROSIC AGENTS.

Country Status (20)

Country Link
EP (1) EP0590094A1 (en)
JP (1) JPH0776215B2 (en)
CN (1) CN1066068A (en)
AU (1) AU1879792A (en)
BR (1) BR9205939A (en)
CA (1) CA2108014A1 (en)
CZ (1) CZ395592A3 (en)
DE (1) DE9290049U1 (en)
FI (1) FI934710A0 (en)
HU (1) HUT65748A (en)
IE (1) IE921330A1 (en)
IL (1) IL101627A0 (en)
MX (1) MX9201916A (en)
NO (1) NO933837L (en)
NZ (1) NZ242493A (en)
PT (1) PT100426A (en)
TW (1) TW197436B (en)
WO (1) WO1992019614A1 (en)
YU (1) YU44592A (en)
ZA (1) ZA922976B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2125325T3 (en) * 1992-01-23 1999-03-01 Pfizer DERIVATIVES OF 4-PHENYL-3- (HETEROARILUREIDO) -1,2-DIHIDRO-2-OXOQUINOLINA AS ANTIHIPERCOLESTEROLEMICOS AND ANTIATEROSCLEROTIC AGENTS.
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
NZ308228A (en) * 1995-05-31 1999-11-29 Sumitomo Pharma Substituted 1,8-naphthyridine derivatives
NZ335766A (en) * 1996-11-26 2000-11-24 Sumitomo Pharma Naphthyridine derivatives and use as acyl-CoA cholesterol acyl transferase(ACAT) inhibitor as treatment of hyperlipidemia
AU2547399A (en) 1998-02-25 1999-09-15 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for producing the same
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
BRPI0417543A (en) * 2003-12-12 2007-03-27 Wyeth Corp quinolines useful in treating cardiovascular disease
CN103601677B (en) * 2013-11-19 2015-11-18 清华大学 Prepare the method for 2-alkylthio quinoline

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
MX22406A (en) * 1989-09-15 1994-01-31 Pfizer NEW DERIVATIVES OF N-ARIL AND N-HETEROARILAMIDAS AND UREA AS INHIBITORS OF ACIL COENZYME A: ACIL TRANSFERASA DEL COLESTEROL (ACAT).
TW205037B (en) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
HUT65748A (en) 1994-07-28
TW197436B (en) 1993-01-01
CA2108014A1 (en) 1992-10-27
HU9303025D0 (en) 1994-01-28
FI934710A (en) 1993-10-25
JPH0776215B2 (en) 1995-08-16
PT100426A (en) 1993-08-31
NO933837L (en) 1993-10-25
AU1879792A (en) 1992-12-21
BR9205939A (en) 1994-09-27
NZ242493A (en) 1994-08-26
IL101627A0 (en) 1992-12-30
ZA922976B (en) 1993-10-25
CN1066068A (en) 1992-11-11
FI934710A0 (en) 1993-10-25
YU44592A (en) 1994-12-28
WO1992019614A1 (en) 1992-11-12
IE921330A1 (en) 1992-11-04
EP0590094A1 (en) 1994-04-06
JPH06501025A (en) 1994-01-27
DE9290049U1 (en) 1994-01-05
CZ395592A3 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
NO932176D0 (en) QUINOLINE, NAFTYRIDINE AND PYRIDOBENZOCSAZINE DERIVATIVES
DE59208263D1 (en) 3-aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
DE10299021I2 (en) Piperazinyl heterocyclic derivatives
LV10099A (en) Bicyclic heterocyclic derivatives
DE69231123D1 (en) Conjugates of cell-binding agents and derivatives of CC-1065
DE69325658D1 (en) SUBSTITUTED THIAZOLIDINDION DERIVATIVES
ATA75293A (en) INDOLDER DERIVATIVES
FR2685328B1 (en) DERIVATIVES OF 2-IMIDAZOLINE-5-ONES AND 2-IMIDAZOLINE-5-THIONES FUNGICIDES.
DE69132519D1 (en) Quinoline derivatives
DE69330497D1 (en) CHINAZOLIN DERIVATIVES
MX9201916A (en) DERIVATIVES OF 4-ARYL-3-HETERO ARYL UREID QUINOLINE AS ANTI-HYPERCHOLESTEROLEMIC AND ANTI-ATHEROSCLEROSIC AGENTS.
DE59308714D1 (en) CYCLOBUTANE-BENZENE DERIVATIVES
DE69119185D1 (en) Derivatives of carboxymethyl chitin and their use
MA22916A1 (en) DERIVATIVES OF 2-IMIDAZOLINE-5-ONES AND 2-IMIDAZOLINE-5-THIONES FUNGICIDES.
NO930520D0 (en) BIFENYL-SUBSTITUTED QUINOLINE DERIVATIVES
FR2698359B1 (en) DERIVATIVES OF 2-ALKOXY 2-IMIDAZOLINE-5-ONES FUNGICIDES.
DK0483702T3 (en) Pulse width modulated amplifier
NO922934D0 (en) CYCLE-HEXAN AND TETRA-HYDROPYRANDER DERIVATIVES
NO952171D0 (en) 3-heteroalipatyl and 3-hetero (aryl) alipatyl-2 (1H) quinolone derivatives
NO952288D0 (en) Benzazepinon derivatives
DE69313890D1 (en) 5-aminoflavone derivatives
FI912963A (en) OEKANDE PYRIMIDINE DERIVATIVES OF HJAERNVERKSAMHETEN.
MX9201635A (en) DERIVATIVES OF INDOL AND DI HIDRO QUINOLINA.
BR9106582A (en) TETRAZOL DERIVATIVES AND MEDICINES
MX9205973A (en) DERIVATIVES OF BENZO-ISOQUINOLINAS.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees